Issue 12, 2012

Commercialization of microfluidic point-of-care diagnostic devices

Abstract

A large part of the excitement behind microfluidics is in its potential for producing practical devices, but surprisingly few lab-on-a-chip based technologies have been successfully introduced into the market. Here, we review current work in commercializing microfluidic technologies, with a focus on point-of-care diagnostics applications. We will also identify challenges to commercialization, including lessons drawn from our experience in Claros Diagnostics. Moving forward, we discuss the need to strike a balance between achieving real-world impact with integrated devices versus design of novel single microfluidic components.

Graphical abstract: Commercialization of microfluidic point-of-care diagnostic devices

  • This article is part of the themed collection: Focus on USA

Article information

Article type
Critical Review
Submitted
05 Dec 2011
Accepted
25 Jan 2012
First published
27 Jan 2012

Lab Chip, 2012,12, 2118-2134

Commercialization of microfluidic point-of-care diagnostic devices

C. D. Chin, V. Linder and S. K. Sia, Lab Chip, 2012, 12, 2118 DOI: 10.1039/C2LC21204H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements